 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- ||||| low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Trial suspension: A Phase ? Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Nov 28, 2023
P2, N=200, Suspended, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Recruiting --> Suspended
- || low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Trial completion date, Trial primary completion date: A Phase ? Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - May 9, 2023
P2, N=200, Recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Recruiting --> Suspended Trial completion date: Oct 2023 --> Dec 2024 | Trial primary completion date: Oct 2022 --> Jun 2024
- || low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Trial completion: A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Sep 6, 2022
P1, N=30, Completed, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Trial completion date: Oct 2023 --> Dec 2024 | Trial primary completion date: Oct 2022 --> Jun 2024 Active, not recruiting --> Completed
- |||| low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
New P2 trial: A Phase ? Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Mar 16, 2022
P2, N=200, Recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
- | low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Trial completion date, Trial primary completion date: A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Feb 22, 2022
P1, N=30, Active, not recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Active, not recruiting --> Completed Trial completion date: Aug 2021 --> Apr 2022 | Trial primary completion date: Jul 2021 --> Feb 2021
- | low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Trial primary completion date: A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - May 28, 2021
P1, N=30, Active, not recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Trial completion date: Aug 2021 --> Apr 2022 | Trial primary completion date: Jul 2021 --> Feb 2021 Trial primary completion date: Dec 2020 --> Jul 2021
- || low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Enrollment closed: A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Sep 28, 2020
P1, N=30, Active, not recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Trial primary completion date: Dec 2020 --> Jul 2021 Recruiting --> Active, not recruiting
- || low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
Enrollment open: A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Jun 23, 2020
P1, N=30, Recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2) / Chongqing Zhifei
New P1 trial: A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02) (clinicaltrials.gov) - Jan 27, 2020
P1, N=30, Not yet recruiting, Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.